MCM
ABEO icon

MAI Capital Management’s Abeona Therapeutics ABEO Stock Holding History

MAI Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3K Buy
9,433
+3,813
+68% +$19.1K ﹤0.01% 2338
2025
Q4 		$29.6K Buy
5,620
+4,000
+247% +$20.1K ﹤0.01% 2306
2025
Q3 		$8.55K Hold
1,620
– – ﹤0.01% 2805
2025
Q2 		$9.2K Hold
1,620
– – ﹤0.01% 2775
2025
Q1 		$7.71K Buy
+1,620
New +$8.81K ﹤0.01% 2591

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MAI Capital Management's ABEO Position: Q1 2026 in Review

MAI Capital Management increased its Abeona Therapeutics (ABEO) stake by 68% in Q1 2026, buying an estimated $19.1K and bringing the position to 9,433 shares worth $42.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

MAI Capital Management first reported a position in ABEO in Q1 2025 and has held it in 5 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • MAI Capital Management held 9,433 shares of Abeona Therapeutics worth $42.3K as of Q1 2026.
  • MAI Capital Management bought 3,813 Abeona Therapeutics shares in Q1 2026, an estimated $19.1K.
  • Abeona Therapeutics made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2338 holding.
  • MAI Capital Management first reported a position in Abeona Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.